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Abstract 
 
S100A9 is a Ca2+ and Zn2+-binding protein which has been increasingly associated with 
Alzheimer’s disease due to its dual roles as a pro-inflammatory and amyloidogenic agent. This 
neurodegenerative condition is characterized by neuroinflammation, amyloidogenesis and also 
disturbance of metal homeostasis. Previous studies have shown that S100A9 is capable to undergo 
self-assembly into dimer, tetramer and larger oligomers, including formation of amyloid fibrils 
as a result of its inherent amyloidogenicity. Interestingly, the formation of these different 
conformational states is thought to be regulated by Ca2+ and Zn2+ binding. Herein, we provide 
insights of how binding of these metal ions influences S100A9 self-assembly reactions using a 
set of complementary techniques, including fluorescence spectroscopy with different 
conformational dyes, conformational antibodies, SEC analysis, turbidimetry assays, and AFM 
imaging. 
The results obtained suggest that Zn2+ binding induces the formation of S100A9 
assemblies and precipitates; albeit these exhibited ThT-reactivity, AFM imaging elicited mostly 
amorphous aggregates rather than amyloidogenic fibril structures. SEC analysis of the formed 
oligomers indicated a size corresponding to that of the S100A9 tetramer, a finding corroborated 
by AFM measurements. Regarding Ca2+-binding effects, thioflavin-T (ThT)-binding kinetics 
indicate the occurrence if a polymerization reaction, which leads to the formations of string-like 
structures as noted by AFM. Interestingly, in control experiments using apo-S100A9, we 
observed that these string-like structures are also formed upon reaction in the same conditions 
with no added metal ions. When exposed to both Zn2+ and Ca2+, we noted that S100A9 forms 
heterogeneous self-assemblies, as inferred from reactivity with different fluorophores including 
luminescent conjugated oligothiophene dyes which are able to detect a wide range of 
amyloidogenic protein aggregates. Interestingly, we observed that metal ion chelation using 
EDTA fully reverts the self-assembly reaction, as shown by disappearance of turbidity, decrease 
in ThT emission and a decrease on AFM-observable oligomers/structures. 
Altogether, the results from this work contribute to unveil possible mechanisms through 
which Zn2+ and Ca2+ binding influences S100A9 self-assembly reaction and will open new 
avenues for investigations on the roles of such assemblies in pathophysiological conditions. 
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Resumo 
 
A causa de doenças neurodegenerativas está muitas vezes associada à formação de 
agregados proteicos e estruturas amiloides. Um exemplo mais representativo desta situação é a 
doença de Alzheimer, que se caracteriza pela existência de um cenário de neuro-inflamação e 
amiloidogénese. Neste contexto biológico, ocorre a acumulação do péptido β-amiloide (Aβ) em 
placas extracelulares e a deposição da proteína tau na forma híper-fosforilada em emaranhados 
neurofibrilares intracelulares. Como consequência deste fenómeno, o principal sintoma da doença 
é a deterioração das capacidades cognitivas, porém, os mecanismos subjacentes a estes sintomas 
não são ainda totalmente compreendidos. Além disso, a desregulação da homeostase dos metais 
é também observada em pacientes que sofrem desta patologia. 
A proteína S100A9 tem vindo a ser frequentemente associada com a doença de Alzheimer 
devido ao seu papel tanto como agente pro-inflamatório e amiloidogénico. A S100A9, também 
conhecida como Mrp14, pertence à grande família das proteínas S100, as quais possuem dois 
domínios EF-hand de ligação a cálcio (Ca2+), ligando também zinco (Zn2+) e cobre (Cu2+) em 
locais distintos dos locais de ligação do Ca2+. Esta proteína é uma das mais potentes proteínas 
pro-inflamatórias da família S100, sendo sobrexpressa em cenários inflamatórios, incluindo a 
inflamação decorrente na doença de Alzheimer. Estudos prévios demonstraram que a proteína 
S100A9 tem a capacidade de se reorganizar-se (self-assembly) em dímero, tetrâmero e também 
em estruturas oligoméricas maiores, onde se inclui a formação de fibras amiloides, como resultado 
da sua amiloidogenicidade inerente. Deste modo, sabendo que esta proteína tem a capacidade de 
ligar Ca2+ e Zn2+, e que, por sua vez, a ligação dos metais a proteínas é um fenómeno que induz 
alterações conformacionais na estrutura das mesmas, foi proposto que a interacção entre a 
proteína S100A9 e os iões metálicos pode ser a causa da agregação amilóide e da citotoxidade 
que advem deste fenómeno. Assim, neste estudo são dadas evidências de como os metais 
influenciam a reacção de self-assembly da proteína S100A9, através do uso de técnicas 
complementares, nomeadamente espectroscopia de fluorescência recorrendo ao uso de diferentes 
sondas conformacionais (ThT, ANS, LCOs: p-FTAA e h-FTAA), ensaios de turbidimetria, uso 
de anticorpos conformacionais (OC e A11), analise por cromatografia de exclusão molecular e 
também microscopia de força atómica (AFM). 
Numa primeira parte deste estudo, foi necessário expressar e purificar o homodímero da 
proteína S100A9 de modo a serem obtidas quantidades significantes de proteína pura, para que 
os subsequentes ensaios pudessem ser efectuados. Para tal, a proteína recombinante humana foi 
expressa em E.coli, seguindo-se uma sequência de etapas, que permitiram isolar os corpos de 
inclusão e extrair as proteínas contidas nestes, incluindo a proteína em estudo. O extracto proteico 
foi após submetido a uma serie cromatografias: cromatografia de dessalinização, para remover o 
cloreto de guanidina (agente desnaturante), cromatografia de exclusão molecular e cromatografia 
de troca-iónica. Finalmente, e dado que o principal objectivo deste estudo era avaliar o efeito dos 
iões metálicos (Ca2+ e Zn2+) na proteína S100A9, foi necessário desmetalar a proteína pura obtida. 
Para tal, o extracto foi incubado com DTT e EDTA, seguindo-se nova cromatografia de exclusão 
molecular, de modo a obter a forma pura final da proteína desmetalada. 
Neste estudo, demonstramos que o Zn2+ tem a capacidade de induzir a agregação da 
proteína S100A9, quando presente em concentrações superiores à capacidade da sua ligação à 
proteína S100A9 e quando esta última está presente numa concentração superior a 10µM 
(concentração critica para agregar). Os agregados formados apresentaram reactividade para com 
a sonda ThT (usada para detetar estruturas amiloides) e foram visíveis, macroscopicamente, sob 
a forma de um precipitado branco, conferindo um aspecto turvo, que possibilitou seguimento 
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deste fenómeno por ensaios onde monitorizou a turbidez da solução a 360 nm. A formação deste 
precipitado ocorreu numa escala de tempo de minutos. Além disso, observou-se que o aumento 
da quantidade de Zn2+ se correlacionou com um potenciamento do processo de agregação, onde 
se observou um aumento do sinal em ambos os ensaios (fluorescência e turbidez) e diminuição 
da fase de inicial (lag phase). Os resultados com as outras sondas conformacionais mostraram 
estar de acordo com a existência desta agregação. No entanto, apesar de os agregados formados 
levarem à formação de espécies reactivas à ThT e aos LCOs, os resultados obtidos através de 
ensaios de seeding, análise por AFM e detecção com os anticorpos conformacionais, OC e A11, 
sugerem que os agregados formados não são de origem amilóide, mas por outro lado que parecem 
ser maioritariamente de natureza amorfa. A divergência de resultados pode ser devida ao facto da 
sonda ThT ter já ter mostrado capacidade de se ligar não só a estruturas amiloides mas também 
de outra natureza. A possibilidade de estes agregados serem induzidos por interações 
electrostáticas que afectam a solubilidade da proteína foi excluída, uma vez que as cinéticas de 
S100A9 em presença de excesso de NaCl não conseguiram reproduzir o mesmo efeito que o Zn2+. 
Por último, a análise das amostras de S100A9 incubadas com Zn2+ (razão 4:1), por cromatografia 
de exclusão molecular, foi possível observar a presença de espécies com um tamanho semelhante 
ao da proteína S100A9 na sua forma tetramérica, o que está concordante com o ensaio de AFM. 
Estes resultados sugerem que o Zn2+ induz a formação de agregados não amiloides, que 
precipitam, com um possível papel na quelação do Zn2+. 
Relativamente ao efeito do Ca2+, sendo este um ligando natural da proteína S100A9, seria 
expectável que a ligação deste ião metálico não induzisse a agregação amilóide da proteína. De 
facto, os ensaios de cinética de ligação das várias sondas conformacionais e de imunodetecção 
pelos anticorpos OC e A11, excluíram a existência de formação de estruturas amiloides. Em 
concordância, as imagens obtidas por AFM indicam a ocorrência de uma reacção de 
polimerização do tipo não-amilóide, onde a proteina S100A9 adquire uma aparência semelhante 
longas “cordas”. Curiosamente, um ensaio controlo usando a forma apo da proteína S100A9, 
revelou a formação de estruturas semelhantes, mesmo sem a adição de iões metálicos. Estas 
evidências sugerem uma possível função biológica destes agregados. 
Curiosamente, quando combinada a ligação de Zn2+ e Ca2+ à S100A9 observou-se um efeito 
aditivo que se refletiu numa agregação heterogénea, com presença de fibras amiloides e outros 
agregados intermediários passiveis de serem observados por AFM e de serem detectados pelos 
anticorpos conformacionais OC e A11. Além disso, todas as sondas mostram reactividade para 
com a S100A9, mas de uma forma sequenciada, demostrando a complexidade deste fenómeno. 
Neste caso, à semelhança da agregação induzida apenas pelo Zn2+, a solução tornou-se túrbida 
com formação de precipitado branco.  
Por fim, é de salientar que foram efectuados ensaios com EDTA, um agente quelante, 
para remover os iões metálicos ligados à S100A9 com o objectivo de verificar a dependência dos 
agregados formados. Assim, foi observada a reversão da reacção de self-assembly pelo 
desaparecimento da turbidez, diminuição da fluorescência da ThT e diminuição dos 
oligómeros/estruturas observadas por AFM. 
Em suma, este estudo contribuiu para revelar possíveis mecanismos, pelos quais a ligação 
de Zn2+ e/ou Ca2+ à proteína S100A9 influencia a sua reacção de self-assembly. Abrindo, assim, 
caminho para investigação dos papéis dos vários agregados em condições patológicas, 
nomeadamente na doença de Alzheimer, e para evidenciar o papel e a relevância da proteína 
S100A9 no despoletar da doença.  
 
 
Palavras-chave: S100A9, agregação proteica, iões metálicos, enrolamento de proteínas  
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1.1. Protein Folding and Misfolding 
 
1.1.1. Protein folding 
Proteins are essential in a variety of biological functions and, to work properly, following 
their synthesis on the ribosome, they must undergo through a complex process named folding. 
This process consists on the acquisition of a specific three-dimensional structure, native 
conformational state, which is encoded in each protein’s own amino acid sequence [1, 2]. 
Uncovering protein folding pathways and the principles underlying this phenomenon is 
considered to be one of the most challenging problems in all structural biology [1-3]. Protein 
folding is a high efficiency and tightly regulated physical process that originates a wide range of 
defined structures which vastly contributed for biological living systems to develop diversity and 
selectivity in their biochemical processes [3]. 
Indeed, only the proteins that have folded correctly will acquire long-term stability in 
crowded biological environments and will be able to selectively interact with their natural 
partners. Consistently, unsuccessful protein folding is frequently associated with pathological 
scenarios [2-6]. 
The folding mechanism results from a set of interactions formed between a specific group 
of amino acid residues that comprises de core of the folding which in turn triggers the folding 
reaction, into the final conformation [7]. The latter corresponds to the so-called native state, which 
tends to be the most stable structure under physiological conditions [8].  
Proteins are structurally organized in a hierarchical manner. The first level of this 
hierarchy is the primary structure, which correspond to the sequence of amino acids that composes 
the protein chain. Within this chain, certain segments tend to fold into simple shapes, such as 
helices and loops, etc, that together constitute the secondary structure. The overall chain tends to 
fold further into a three-dimensional compact tertiary structure, the most stable form of the 
protein, since it optimizes the various attraction forces between the different amino acids residues. 
Moreover, the tertiary structure correspond to active form of the protein, thus it is often referred 
to as the native structure of the protein. These levels of structure exist in all proteins, although 
sometimes deviations from the classical “rules” occur, namely in the formation of fibrous proteins 
[9]. Some proteins are composed of more than one chain, in which cases the tertiary structure is 
not the final hierarchical level of structure. In these cases, each chain must fold separately into a 
tertiary structure and then join together to form a biologically active complex, referred to as 
quaternary structure [9]. 
In order to achieve the native state, proteins have to find their way to this unique 
conformation rather than one of the countless alternatives. Preferable folding pathways are 
determined by the folding landscape of protein which can be conceptually described as a funnel 
[10]. This concept allows the correlation between free energy changes and the protein’s three-
dimensional structure (Figure 1.1.1) [7]. The top of the funnel contains a wide variety of unfolded 
conformations characterized by high energy levels resulting from a large conformational entropy 
[10]. Contrarily, the bottom of the funnel presents an energetic minimum corresponding to the 
most stable structure under physiological conditions [10].  
The energetics of protein folding can be described by the central thermodynamic equation 
(equation 1): 
∆𝐺 = 𝛥𝐻 − 𝑇∆𝑆 (Equation 1.1.1) 
In this equation, ΔH represents the additive contributions of chemical bonds and 
interactions, while −TΔS correspond to the variations in the degree of order within the system [8]. 
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Figure 1.1.1 – The free energy landscape for protein folding. Folding occurs through the progressive organization of 
ensembles of structures on a funnel-shaped free energy landscape. Conformational entropy loss during folding is 
compensated by the free energy gained as more native interactions are formed. Kinetics is determined by the local 
roughness of the landscape, relative to thermal energy. Adapted from [10]. 
 
Folding in vivo can occur in different occasions and cellular locations. On the one hand, 
it can happen co-translationally, when the nascent chain is still attached to the ribosome [11]. On 
the other hand, in most case protein folding occurs in the cytoplasm after translation. Additionally, 
folding can take place in subcellular compartments, such as the mitochondria or the endoplasmic 
reticulum (ER), after the translocation of the polypeptide chain through the organelle membrane 
occurs [12, 13]. The particular environment in which folding takes place makes a difference in 
many details, however the fundamental principles of folding are indeed universal [3]. 
 
 
1.1.2. Protein folding regulation 
Considering the above-mentioned complexity of the protein folding process, misfolding 
events can happen, therefore leading to unsuitable interactions with other molecules inside of the 
cell [14]. As such, living systems have strategically evolved to prevent such phenomena [12-14]. 
The folding process takes place in a complex and highly crowded environment, where it is aided 
by auxiliary proteins, termed molecular chaperones, whose role is to secure the protein’s proper 
folding [12-16]. Chaperones act both in an early stage of protein synthesis, interacting with the 
chain as it emerges from the ribosome, and also at later stages, guiding the protein folding after 
the dissociation from the ribosome [12, 13].  
The role of molecular chaperones in protein folding is to increase the efficiency of the 
overall process by reducing the probability of competing reactions, particularly misfolding and 
ultimately aggregation. Thus it is often observed the tandem work of different molecular 
chaperones to guarantee the success of the various stages of the protein folding [3]. 
One of main classes of molecular chaperones are the heat shock proteins (Hsps). Hsps are 
especially induced in conditions of cell stress, which is consistent with their role in preventing 
misfolding. Hsps are classified according to their molecular weight (Hsp40, Hsp60, Hsp70, 
Hsp90, Hsp100…) and are involved not only in protecting proteins as they fold but also in 
rescuing misfolded and even aggregated proteins, allowing them to fold correctly [12, 13]. 
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Potentially slow steps in the folding process can be accelerated by a group proteins that 
act as folding catalysts, such as peptidylprolyl isomerases and protein disulphide isomerases. 
Their role is to increase the rate of the cis–trans isomerization of peptide bonds comprised in 
proline residues, and to increase the rate of formation and reorganization of disulphide bonds, 
respectively [17]. 
As mentioned above, folding can take place in different cellular locations. In this context, 
newly synthesized proteins, meant for secretion, are translocated to the ER, where the folding 
process happens. In the ER, proteins are subjected to a “quality-control” check that involves a 
series of glycosylation and deglycosylation reactions that tags proteins, allowing the distinction 
between the correctly folded from misfolded ones (Figure 1.1.2) [18, 19]. Misfolded proteins are 
targeted for degradation [20]. This mechanism is also upregulated in stress conditions [21]. 
 
  
Figure 1.1.2 - Regulation of protein folding in the ER. Many newly synthesized proteins are translocated into the ER, 
where they fold into their three-dimensional structures with the help of a series of molecular chaperones and folding 
catalysts (not shown). Correctly folded proteins are then transported to the Golgi complex and then delivered to the 
extracellular environment. However, incorrectly folded proteins are detected by a quality-control mechanism and sent 
along another pathway in which they are ubiquitinated and then degraded in the cytoplasm by proteasomes. Adapted 
from [19]. 
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1.1.3. Metal ions and protein folding 
Metal ions are essential for virtually all organisms and metal-binding proteins constitute 
around one third of the proteome [8]. Among others, metal cations such as iron (Fe3+/Fe2+), zinc 
(Zn2+), copper (Cu2+/Cu+), calcium (Ca2+), magnesium (Mg2+) or manganese (Mn2+/Mn3+) are 
extremely important in biological processes such as electron transfer reactions, catalysis and 
stabilization of the protein structure [22]. The protein-metal association leads to a series of 
adjustments on the protein fold that results from a compromise on coordination numbers, bond 
lengths and angles which are imposed both on the metal and on the protein fold [8]. These changes 
alter protein energetics, thus influencing its stability and dynamic properties [22]. There are amino 
acid residues, such as histidine, cysteine, aspartate and glutamate, that have high affinity to certain 
metals resulting in a selectivity pattern [22-24]. Hence, there are preferable combinations of 
amino acids residues, which constitute metal coordination motifs, whose interaction with the 
metal ion ensures its proper insertion in a catalytic or structural site (Table 1.1.1) [8]. 
 
Table 1.1.1 – Typical coordination environments of selected metal cations in proteins. Adapted from [8]. 
Metal 
cation 
Bond 
stability 
Coordination 
number 
Side chain 
ligands 
Coordination geometry 
Zn2+ High 3 His, Cys, Glu Severely distorted tetrahedron 
Cu+ High 3,4 His, Cys, Met Severely distorted tetrahedron 
Cu2+ High 3,4 His, Cys Distorted square planar 
Ca2+ Intermediate 7 (8) Glu, Asp Pentagonal bipyramid, trigonal 
prism, distorted octahedron 
Fe2+ Low 
 
4–6 His, Glu, Asp 
Cys 
Distorted octahedron 
tetrahedron 
Fe3+ 
 
High 4–6 Glu, Asp, Tyr 
Cys 
Distorted octahedron 
tetrahedron 
 
Generally, the protein-metal association involves both electrostatic and coordinative 
interactions, but in around one third of metalloproteins metal binding is essentially coordinative 
[8, 24]. Alternatively, this interaction can be established indirectly via a metal cluster or a larger 
chemical group [8].  
When multiple binding sites are involved, the protein fold energetics become more 
complex due to cooperative events. In this cases, when a metal binds or dissociates from one site, 
conformational adjustments occur that affects the coordination sphere and binding energetics of 
another site, either by increasing (positive cooperativity) or decreasing (negative cooperativity) 
its affinity [8]. 
It is now clear that metal binding modulates both the protein folding landscape and 
folding trajectories [25, 26]. Thus, living systems have created a complex protein machinery 
whose function is the maintenance of metal ion homeostasis [8]. The metal delivery to 
polypeptides is assured by metallo-chaperones, whose role is to deliver the metal ion to its target 
hollo protein [27]. There are three generic scenarios of the mechanisms that mediate metal 
insertion into newly folded proteins: co-translational metal ion binding; post-translational metal 
ion binding to incompletely folded proteins; and post-translational metal ion binding to folded 
apo proteins [24].  
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1.1.4. Protein aggregation and amyloid formation 
In addition to the native globular structure, proteins can populate other states, including 
disordered and partially ordered conformations, and different aggregated assemblies, which are 
important to cell homeostasis including growth, development and proliferation (Figure 1.1.3) [3]. 
The state a protein adopts under specific conditions depends on the relative thermodynamic 
stabilities of the many accessible conformations and on the kinetics of their interconversion 
(Figure 1.1.3) [2, 28]. The transitions between the different states are highly regulated by the 
environment and by the presence of molecular chaperones and degradation mechanisms. 
Therefore, aberrant behavior of the chaperones and other intervenients can be a key factor for 
development of misfolding and aggregation diseases (Table 1.1.2) [21, 29]. 
 
Table 1.1.2 – Representative protein folding diseases. Adapted from [2]. 
 
  
Figure 1.1.3 – States accessible to a protein molecule. Adapted from [28]. 
Disease Protein Site of folding 
Hypercholesterolemia low-density lipoprotein receptor ER 
Cystic fibrosis Cystic fibrosis trans-membrane regulator ER 
Phenylketonuria Phenylalanine cytosol 
Huntington’s disease Huntingtin cytosol 
Marfan syndrome Fibrillin ER 
Osteogenesis imperfecta procollagen ER 
Sickle cell anaemia hemoglobin cytosol 
αl-antitrypsin deficiency αl-antitrypsin ER 
Tay-Sachs disease β -hexosaminidase ER 
Scurvy Collagen ER 
Alzheimer’s disease β-amyloid/presenilin ER 
Parkinson’s disease α-synuclein cytosol 
Scrapie/Creutzfeldt-Jakob disease prion protein ER 
Familial amyloidoses transthyretin/lysozyme ER 
Retinitis pigmentosa rhodopsin ER 
Cataracts crystallins cytosol 
Cancer p53 cytosol 
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Amyloid fibrils are the most well studied type of protein aggregate, given its unique 
kinetic and thermodynamic stability that culminates a progressive build-up of deposits in tissues. 
As a consequence, these deposits can physically disrupt specific biological components such as 
organs and tissues, thereby leading to a pathological behavior [5]. 
Several peptides and proteins that are involved in the most common misfolding diseases, 
such as the amyloid-β peptide in Alzheimer’s disease [30, 31] and α-synuclein in Parkinson’s 
disease [32, 33], form amyloid fibrils. Although their soluble forms have distinct characteristics, 
the aggregated forms are typically similar, characterized by their cross-b structure, in which 
β-strands form effectively continuous hydrogen-bonded β-sheets that run along the length of the 
fibril [34, 35]. Amyloid fibrils tend to appear as unbranched filamentous structures with a few 
nanometers in diameter but often micrometers in length (Figure 1.1.4) [36]. 
 
 
Figure 1.1.4 - Structure of an amyloid fibril at atomic resolution. Adapted from [36]. 
 
This phenomenon is not restricted to a small number of proteins, but instead it seems to 
be a generic feature of polypeptide chains, since it has been shown that fibrils can be formed in 
vitro by many other peptides and proteins, under specific conditions [2, 37, 38]. However, the 
propensity to form amyloid fibrils under given circumstances can differ between different amino 
acid sequences. The amyloidogenic propensity of a given peptide or protein correlates with its 
physicochemical features, such as charge, secondary-structure propensities and hydrophobicity 
[39].  
The highly ordered and compact structure, provides an exceptional high level of kinetic 
and thermodynamic stability to the fibrils, which led to the assumption that the amyloid state 
might be more stable than the functional native state of a protein, even under physiological 
conditions [40, 41]. However, in the amyloid state intramolecular interactions are predominant 
and essential, which means that its thermodynamic stability (ΔG) is dependent on the protein 
concentration [42]. Thus, the amyloid state in only more stable than the native state when the 
critical concentration is achieved and the free energy (G) of the peptide or protein is lower than 
its native state. This evidence suggests that proteins might occasionally function at concentrations 
that exceed their conventional thermodynamic solubility [41, 43]. 
 
 
Figure 1.1.5 – Thermodynamics of the amyloid state. Adapted from [40]. 
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The formation of amyloid fibrils has been characterized, by in vitro studies, as a typical 
nucleated process composed by a lag phase, followed by a period of rapid growth [44, 45] and if 
the total amount of protein is limited, this process ends with a plateau phase as a result of the 
depletion of all soluble species and its conversion into fibrils (Figure 1.1.7). The self-assembly 
into amyloid fibrils begins with the formation of soluble oligomers resulting from nonspecific 
interactions, however, in some cases, specific structural transitions are a key factor [46]. The 
earliest species generally are characterized as small bead-like structures, sometimes linked 
together, often described as amorphous aggregates or micelles. Sequentially, the “prefibrillar 
aggregates” give rise to short, thin and sometimes curly fibrillary species termed “protofilaments” 
or “protofibrils”. Finally, the latter species are thought to assemble into long mature fibrils (Figure 
1.1.6) [3]. 
 
 
Figure 1.1.6 – General mechanism of aggregation to form amyloid fibrils. The earliest species generally resemble 
bead-like structures (D), thereafter transform into structures called protofibrils or protofilaments (A) which in turn 
assemble into mature fibrils (B). Adapted from [3]. 
 
Besides classic nucleation, the amyloid formation can be triggered by templating or 
seeding [47, 48] from existing aggregates. Templating is the mechanism by which structured 
aggregates promote the conversion of soluble protein species into similar aggregates [42]. On the 
other hand, the seeding process occurs when aggregates are used to promote the formation of 
larger aggregates, eliminating the lag phase [42]. 
The nucleation process can also involve secondary steps that depend on the behavior of 
the aggregates being formed [49, 50] (Figure 1.1.7). In this cases, formation of new aggregates 
arises from existing fibrils through fragmentation or from a combination of both monomeric and 
aggregated species through secondary nucleation [49, 50]. 
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Figure 1.1.7 - Kinetics of amyloid formation. Adapted from [42] 
 
The formation of these fibrils is known to be associated with both protein loss of function 
and generation of toxic intermediates in the process of self-assembly, which in turn are the basis 
of many misfolding diseases [30, 31, 49, 51-57]. Thus, living systems have evolved to avoid the 
formation of such fibrils by alternating amino acid residues with polar and hydrophobic 
characteristics [58, 59] that favor b-sheet structure seen in amyloid fibrils or by inserting highly 
aggregation-resistant residues, known as “gatekeepers” [58, 60], and by controlling proteins 
structure by means of molecular chaperones and degradation mechanisms [61-63].  
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1.2. S100 proteins 
1.2.1. Function and structural characteristics of S100 proteins 
S100 proteins belong to the EF-hand calcium-binding protein superfamily constituted by 
24 members of low molecular weight (10–13 kDa) [64]. These proteins were named S100 by 
Moore, due to their solubility in 100% saturated ammonium sulfate [65]. 
Importantly, S100 proteins are expressed exclusively in vertebrates, exhibit tissue, cell, 
and subcellular-specific expression patterns [64, 66], and are induced by specific growth factors, 
cytokines and toll-like receptor (TLR) ligands [67-72]. In pathological conditions, however, the 
expression of a particular S100 protein can be triggered in a cell type that does not express it in 
normal physiological conditions [73-78]. The majority of the human S100 genes, are located 
within chromosome 1q21, except S100A11P, S100B, S100G, S100P and S100Z which map to 
chromosome 7q22-q3, 21q22, Xp22, 4p16 and 5q13, respectively [64]. 
All S100 proteins possess highly conserved overall structural architectures, although their 
sequences share no more than 25–65% homology [79]. Like other EF-hand Ca2+ binding proteins, 
the S100 proteins contain two calcium-binding EF-hand motifs bridged by a so called hinge 
region, that are highly conserved among the S100 family members (Figure 1.2.1) [80, 81]. A 
single monomer is composed of two calcium-binding helix-loop-helix motifs, containing four 
helices (helix I, II, III, and IV) (Figure 1.2.3) [80, 81]. 
These proteins are distinguished from other EF-hand proteins by their both intracellular 
and extracellular functions, their tendency to form homodimers, and the ability to bind transition 
metals at the dimer interface [82]. Some members of the S100 protein family are also able to form 
heterodimers, for example S100A8 and S100A9 or S100A1 and S100P, suggesting different 
functions for homo- and heterodimers [82]. Moreover, in many situations, biological functions 
and signalling are carried out by S100 proteins that form higher order non-covalent oligomers, 
which can be promoted through binding of metal ions, such as Ca2+ and transition metals 
(particularly Zn2+) [82, 83]. These oligomers include tetramers (S100B [84] , S100A2 [85], and 
S100A8/A9 [86]), hexamers (S100B [84], S100A12 [87, 88]), and octamers (S100B [84]). 
Regarding intracellular functions, S100 proteins are involved in the regulation of several 
biological processes such as proliferation, differentiation, apoptosis, Ca2+ homeostasis, energy 
metabolism, inflammation and migration/invasion, through the interaction with a variety of 
targets, namely enzymes, receptors, transcription factors and nucleic acids [89]. On the other 
hand, at extracellular level, S100 can regulate functions of target cells in an autocrine and 
paracrine manner via activation of surface receptors [89]. 
It has been shown that several S100 proteins have the ability to undergo β-aggregation, 
as a cause or consequence of pathophysiological states [90]. Indeed, an example is the S100A8/A9 
heterodimer that was found in amyloid deposits from prostate cancer patients, in inclusions called 
copora amylacea [91]. Moreover, there is the assumption that S100 proteins have intrinsic 
disordered regions [92] and the propensity to form amyloid-like structures [91]. 
 
 
Figure 1.2.1 – Structural features of S100 proteins. Ribbon diagrams of (A) and EF-hand motif (B) and EF-hand 
domain and (C) the integration of two EF-hand domains into a S100A9 dimer. Adapted from [82].  
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1.2.2. Metal binding to S100 
The ability of the S100 proteins to bind different metals, such as Ca2+, Zn2+ and Cu2+, is 
a matter of great interest since it is known that these metals can have an effect on the structure, 
function and biochemical properties of the protein [82]. Both Ca2+ and transition metals 
(particularly Zn2+) have been shown to stimulate oligomerization in vitro, and crystal structures 
have revealed a range of oligomeric states [82]. 
As mentioned above, the S100 proteins bind Ca2+ ions through their EF-hand domains 
[80, 81]. Typically, EF-hand Ca2+-binding motifs are arranged in pairs of EF-hands held together 
by a very short anti-parallel β-strand and numerous hydrophobic interactions between the four 
helices [82]. S100 family members are an unique set of EF-hand family, because one of the EF-
hand motifs in the pair (designated as a pseudo- or S100-hand) has 14, rather than 12 residues 
(canonical EF-hand [93]), characterized by the lower affinity towards Ca2+ [94]. Each monomer 
is comprised of a S100-specific N-terminal EF-hand with a 14-residue Ca2+ binding loop, and a 
C-terminal EF-hand with a canonical 12-residue Ca2+ binding loop [80]. Since the proteins are 
dimers, each protein bind four Ca2+ ions, however, there are different affinities for this metal [82]. 
Similar to other EF-hand proteins, the S100 response to Ca2+ signals is characterized by 
conformational changes upon ion binding, which involves a significant shift in the orientation of 
Helix III, a 90 degree rotation (Figure 1.2.2) [95]. Moreover, this Ca2+-induced conformational 
change leads to the exposure of a hydrophobic region necessary for the interaction with its specific 
protein targets. The hydrophobic region is composed by residues from the “hinge” section, Helix 
III and C-terminal, being the region with highest variability within the S100 family members [95-
97]. 
As abovementioned, despite being structurally similar, S100 proteins are able to interact 
with a plethora of cellular targets. This characteristic diversity is secured by the fine tuning within 
the target binding site of each S100 protein, specific expression patterns and the metal-binding 
ability [98]. 
 
 
 
Figure 1.2.2 – Comparison of single sub-units of S100A12 to emphasize the differences in the packing of Helix III 
induced by Ca2+ and transition metals. This reveals that the consequences of binding Ca2+ are much greater than those 
of binding transition metals. Adapted from [82]. 
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Interestingly, S100 proteins bind not only Ca2+ but also transition metals, such as zinc and 
copper, in other sites [99]. Indeed, the binding of Zn2+ to an S100 protein was firstly reported for 
the S100B protein [100]. However, it is now known that Zn binding occurs in several S100 
proteins (S100A1, S100A2, S100A3, S100A5, S100A6, S100A7, S100A8/A9, S100A12, 
S100A16 and S100B), with high affinity ranging from Kd=4 nmol L−1 (S100A3) to 100 μmol 
L−1 (S100A7). The Zn2+ binding S100 proteins can be classified into two categories: His-rich 
and Cys-rich [82]. 
Different studies [82] have revealed a conserved binding motif for the proteins with His-
rich sites, composed by 4 His residues, or 3 His and 1 Asp residues, located at the dimer interface 
(Figure 1.2.3). Since the proteins are dimers, each protein binds two Zn2+ at the two symmetrically 
disposed sites (Figure 1.2.4). 
For the S100A7 and S100A12 it has been shown, through a detailed comparative 
structural analysis between all states (apo form, Ca2+- and Zn2+-loaded), that in the Zn2+-loaded 
structures of S100A7 and S100A12, two Zn2+ ions are bound at the symmetrically disposed sites 
(Figure 1.2.4 A), coordinated by three His N2 atoms (His17, His86, His90) and an aspartate side 
chain (Asp24) (Figure 1.2.4 A) [99, 101]. In all cases, the primary effect of Zn2+ is to alter the 
orientation of Helix III (Figure 1.1.2).  
 
 
Figure 1.2.3 – Alignments of S100 proteins containing transition metal binding sites. Structure based sequence 
alignment of S100 proteins from the (A) His-rich and (B) Cys-rich categories. Conserved residues in His-rich sites are 
highlighted with blue background, and those in Cys-rich sites in red background. Adapted from [82]. 
 
 
Figure 1.2.4 – Structural similarity of tetrahedral zinc and copper binding sites in S100 proteins. (A) Overlay of the 
structures of (Ca2+)4, (Zn2+)2-S100A7 (light green), (Ca2+)4, (Zn2+)2-S100B (blue) and (Ca2+)4, (Cu2+)2-S100A12 (purple) 
showing that the transitions metal ions are chelated in similar manner by side chains in the same position in the 
sequence. (B) Zoom in on the tetrahedral Zn2+ and Cu2+ sites showing the similar spatial disposition of the 3 His and 1 
Asp chelating side chains. The Zn2+ and Cu2+ ions are colored gray and orange, respectively. Adapted from [82]. 
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Regarding the Cys-rich Zn2+ binding S100 proteins (S100A2, S100A3, S100A4), these 
proteins are much less studied than the His-rich group [102], due to the absence of a conserved 
motif evident from alignment of these proteins 
The possibility of different metals binding to an S100 protein, suggests scenarios where 
a crosstalk between metals that bind to S100 proteins is expected. In this context, it has been 
reported for the S100B that Zn2+ binding leads to an increase of the Ca2+ affinity by a factor of 10 
and for the S10012 by ~1500 fold [102]. On the other hand, it lowers the Ca2+ affinity of S100A2 
[85] and have no effect on S100A5 [103].  
Due to Cu2+ and Zn2+ similar chemical properties, it was expected that Cu2+ would bind 
to most zinc binding sites in proteins. Moreover, ion competition experiments demonstrated that 
the Cu2+ ions could be displaced by Zn2+, but not Ca2+. Thus, as expected, the S100 proteins bind 
Cu2+ in a similar way they bind Zn2+. There is still few information about the effects of Cu2+ 
binding on S100 proteins, but it seems that the overall conformational change induced by the 
binding of Cu2+ is very small compared with Ca2+ or Zn2+ binding [82]. 
 
 
1.2.3. S100A9 
The work developed in this thesis is about the S100A9 homodimeric form and how it 
reacts to binding of metals and aggregation conditions. 
S100A9, also known as Mrp14, is a Ca2+- and Zn2+-binding protein with a molecular 
weight of 13.242 kDa, composed by 114 amino acids and has the longest C-terminal region in its 
sequence among the S100 family members (Figure 1.2.6). S100A9 is one of the most potent pro-
inflammatory protein in the S100 family, being overexpressed in several inflammation scenarios, 
including inflammation associated with Alzheimer’s disease [104]. 
The S100A9 is one of the major constituents of neutrophils which plays an important role 
in the regulation of inflammatory and immune response [105]. This protein exists preferentially 
as a heterodimer or heterotetramer with S100A8 known as calprotectin [106, 107]. However, it 
can also exist as homodimer [108] and higher oligomeric species, including, fibrillary structures 
due to its intrinsic amyloidogenicity [91]. Dimerization is achieved by anti-parallel interactions 
between helices H1 and H4 of each monomer (Figure 1.2.6) [108]. Each of these forms assumes 
specific functions and their formation is dependent on binding of divalent cations, such as calcium 
and zinc [108]. 
Current research on this protein is focused on its association with numerous human 
disorders, including acute and chronic inflammatory conditions, autoimmune diseases, cancer, 
atherosclerosis, cardiomyopathies and neurodegenerative diseases [104, 106-108], given its 
crucial role in normal physiological processes within cells. 
 
Figure 1.2.5 – S100A9 homodimer crystal structure (CHAPS removed). The Ca2+ ions are colored green. Images 
generated in pymol using PDB entry 1IRJ.  
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Primary Structure, Ca
2+
- and Zn
2+
-Binding Sites 
Like other S100 proteins, S100A9 contain two EF-hand Ca2+-binding sites: a C-terminal 
canonical EF-hand (site II) and a N-terminal pseudo EF-hand (site I) with a 12 and 14 amino acid 
residue Ca2+-binding loop positioned between two supporting α-helices, respectively (Figure 
1.2.6) [108]. The alignment of these motifs with other members of the S100 family has 
demonstrated that in both sites S100A9 contains the conserved sequence determinants required 
for Ca2+-binding [108].  
The Ca2+-binding site II include residues Asp67-Glu78 and interacts with Ca2+ through 
seven oxygen ligands, forming a pentagonal bipyramidal coordination: the side-chain O atoms of 
Asp67, Asn69, Asp71 and Glu78, the main-chain carbonyl O atom and a water molecule. The 
Ca2+-binding site I include residues Ser23–Glu37 and interacts with Ca2+ through seven O atoms 
from the main-chain carbonyl groups of Ser23, Leu26, His28 and Thr31, the carboxyl group of 
Glu36 and a water molecule (as indicted in Figure 1.2.6) [108]]. The water molecule as a seventh 
ligand also forms a hydrogen bond with the side-chain of Thr31. 
Although it is know that S100A9 is important for Ca2.-dependent functions during 
inflammatory conditions, the function behind the Ca2+-S100A9 interaction is yet to be unveiled 
[108]. However, it has been shown that Ca2+ is capable of inducing S100A8/A9-tetramerization 
[109]. 
 
 
Figure 1.2.6 – Amino acid sequence alignment of the human S100 family of proteins. Proteins whose three-dimensional 
structures have already been analysed are marked by an asterisk. Secondary structure elements of S100A9 are given. 
Residues that coordinate calcium ions are marked as follows: m, main-chain carbonyl group; s, mono-dentate side-
chain of Asp or Asn; b, bi-dentate side-chain of Glu. The residues highlighted in blue are well-conserved residues the 
side-chains of which coordinate calcium ions. The residues highlighted in yellow represent highly conserved 
hydrophobic residues forming an intra-monomer hydrophobic cluster. Residues that interact with target molecules are 
marked with $. The residues highlighted in pink are other conserved hydrophobic residues that form an inter-monomer 
hydrophobic cluster. All sequences were obtained from the SWISS-PROT protein sequence database [110]. Adapted 
from [108].  
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Besides Ca2+, S100A9 also bind Zn2+ ions. S100A9 is classified in the his-rich category 
of the Zn2+ binding S100 proteins and contain HEXXH motives in its sequences that are putative 
Zn2+-binding sites [111]. 
The role of zinc in S100A9 is still unclear, however it has been reported that S100A9 
chelates zinc as a biological function [112]. Moreover, different biophysical methods have shown 
that Zn2+-induces S100A8/A9-tetramerization by binding to both Ca2+-specific EF-hands and 
Zn2+-specific binding sites [113, 114]. The researchers who carried out this study reported that 
twelve Zn2+ were bound to the tetramer (eight Zn2+ bound to the EF-hands and four Zn2+ to the 
Zn2+-specific binding sites) [113, 114], revealing the existence two different putative Zn2+-binding 
sites on the S100A8/A9 subunit interface. 
Interestingly, several other S100 family members are also regulated by Zn2+ and Ca2+ 
[115], as mention earlier, and for some of them the Zn2+-binding sites have been well 
characterized (S100B, S100A2, S100A7 and S100A12) by different techniques [116, 117]. For 
these proteins it was observed the binding of two Zn2+-ions per homodimer and that both subunits 
provide residues to form the Zn2+-binding sites. Since the Zn2+-binding residues in S100A9 and 
S100A7 are fully conserved, it is likely that the S100A9 homodimer coordinates Zn2+ in a similar 
way as S100A7 [86, 118].  
 
 
1.2.4. S100A9 in Alzheimer’s disease 
As aforementioned, S100A9 is involved in several human disorders, including 
Alzheimer’s disease (AD). AD is a neurodegenerative disorder characterized by the accumulation 
of amyloid-β protein (Aβ) in extracellular plaques and the deposition of hyperphosphorylated tau 
protein in intracellular neurofibrillary tangles [119-121], which are directly associated with 
prominent neuroinflammation [122]. In turn, this condition is correlated with a severe 
deterioration of cognitive function [123], however the molecular mechanisms underlying this 
observation are yet to be unveiled [124, 125]. Furthermore, aberrant metal homeostasis seems to 
be related with AD pathogenesis [126]. 
S100A9 plays an important role in regulating vascular inflammation, by recruiting 
leukocytes to damaged vessels, such as those injured by deposition of Aβ amyloid fibrils [127]. 
Moreover, an overexpression of S100A9 has been reported in microglia in the temporal cortex of 
both familial and sporadic AD cases [128], suggesting that S100A9 could be a neuroinflammatory 
marker of AD. 
The accumulation of Aβ amyloid fibrils on cerebral vessels and in brain parenchyma 
leads, consequently, to local inflammation [129], which in turn results in activation and 
recruitment of microglia to the plaque deposition site [130], causing microgliosis. From this point, 
microglia acts in two ways: beneficial promotion of phagocytosis of Aβ and harmful production 
of neurotoxins and pro-inflammatory molecules [131-133], such as S100A9. The high levels of 
S100A9 on Aβ amyloid fibril deposits promotes further inflammation and enhances Aβ amyloid 
fibrils formation. Moreover, S100A9 drives microglia into a pro-inflammatory state thereby 
compromising microglial phagocytosis [131, 134]. 
Among this events, BACE1 activity is also elevated, resulting in increased Aβ production 
[135], which in turn further accelerate S100A9 expression, creating a vicious cycle that promotes 
and expands the deposition of Aβ amyloid fibrils including amyloid-associated proteins on 
cerebral vessels and in brain parenchyma (Figure 1.2.7). 
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Figure 1.2.7 – A comprehensive model of amyloid fibril formation enhancement. Local inflamation by Aβ amyloid 
deposition induces S100A9 production by activated phagocytes and up-regulation of the inflamatory condition. 
Thereafter, S100A9 induces increased formation of Aβ amyloid fibril and futher inflamation. Moreover S100A9 drives 
microglia into proinflamtory state thereby compromising microglial phagocytosis. Adapted from [136]. 
 
Due to its inherent amyloidogenicity, the significantly increased levels of extracellular 
S100A9 leads to its amyloid aggregation [137-139] and also co-aggregation with Aβ [140], 
enhancing each other aggregation, suggesting a “rescue” clearance process to remove neurotoxic 
amyloid species from circulation. However, the consequences of this clearance process can lead 
to exacerbated growth of the amyloid plaques in AD brain, much more stable and protease 
resistant [91]. Furthermore, the plaques themselves can lead to more microglia activation, thus 
completing the vicious circle of amyloid-neuroinflammatory cascade.  
Interestingly, the knockdown or knockout of the S100A9 gene in AD mice model 
(Tg2576) significantly reduced the neuropathology and the amount of Aβ, C-terminal fragments 
of amyloid precursor protein (APP-CT) and phosphorylated tau [141]. 
Therapeutic strategies for AD treatment focus on inhibiting Aβ production and/or enhancing 
Aβ clearance [136]. Therefore, due to its amyloidogenicity, neurotoxicity and signaling functions, 
S100A9 may be a promising therapeutic target. However, the specific role of S100A9 in AD as 
well as in aging is still far from clear. 
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1.3. Methods for structural analysis and protein 
folding monitoring 
 
1.3.1. Fluorescence spectroscopy 
Fluorescence spectroscopy is an important investigation tool in different areas of 
analytical science, due to its high sensitivity and selectivity. Its applications include the study of 
protein folding, structural dynamics and protein interactions by monitoring the tertiary structure 
of proteins [142]. For many proteins this application is possible due to their intrinsic fluorescence 
granted by the presence of aromatic amino acid residues, such as the tryptophan (Trp), tyrosine 
(Tyr) and phenylalanine (Phe). These residues and other fluorescent molecules are called 
fluorophores. Besides intrinsic fluorophores there are some extrinsic probes that also give 
information about the protein folding, misfolding and ultimately amyloid formation. The probes 
used in this work were: Thioflavin-T (ThT); 8-anilino-1-naphthalenesulfonic acid (ANS); and 
two luminescent conjugated oligothiophenes (LCOs), p-FTAA and h-FTAA. 
ThT is a benzothiazole dye that exhibits enhanced fluorescence upon binding to amyloid 
fibrils. Originally, it was thought that ThT only interacted with the amyloid cross-β structure 
[143], however, it has been shown that ThT fluorescence can bind to non-β-sheet cavities 
(observed for acetylcholinesterase and γ-cyclodextrin) [144]. The binding leads to an increase in 
fluorescence intensity and induces a shift in the maximum wavelength from 483 nm to 478 nm 
[145]. 
ANS is known to interact with hydrophobic sites, such as the ones buried within the 
protein. For this reason this probe has been widely used in protein folding and binding studies, 
where sometimes hydrophobic regions exposure occurs. Once more, this interaction leads to an 
increase in fluorescence intensity and induces a shift in the maximum emission wavelength, from 
530 nm to 475 nm [142]. 
LCO’s are anionic oligothiophene based ligands capable of detecting non-
thioflavinophilic aggregated species preceding amyloid fibril formation. They presumably 
intercalate with the amyloid fibrils by binding in grooves along the long axis of the amyloid fibril 
[146]. The ones used in this work where the p-FTAA and h-FTAA, each with distinct spectral 
signature. The binding of this probes leads to the increase of their fluorescence intensity [146].  
 
 
Figure 1.3.1 – ThT, ANS, p-FTAA and h-FTAA chemical structures and respective excitation emission wavelengths.  
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1.3.2. Conformation studies by Imunodetection 
The formation of amyloid deposits is a characteristic feature of many degenerative disease 
and its staining in human and mice AD brains has been a challenge. However, it has been 
overcome by the development of conformation-dependent antibodies that specifically recognize 
generic epitopes of a polypeptide chain with given conformation, regardless of its sequence. This 
antibodies include the OC and A11. The OC antibody recognizes amyloid fibrils, while the A11 
specifically recognizes a generic epitope common to prefibrillar oligomers [147, 148]. 
 
 
Figure 1.3.2 - Dotblot resulted from detection of fibrils and oligomers, from different proteins, by the 
conformation-dependent antibodies A11 and OC [148]. 
 
 
1.3.3. Atomic Force Microscopy 
Atomic Force Microscopy (AFM) is the most versatile and high-resolution scanning 
method for studying samples at nanoscale. An AFM uses a cantilever with a sharp tip to scan 
samples adsorbed on atomically flat smooth surfaces, typically mica. As it goes along the surface 
the cantilever deflects vertically and laterally producing a signal which is translated to generate a 
corresponding topography image. This technique has been used to investigate the self-assembly 
dynamics of several amyloidogenic proteins and other types of aggregates [149]. 
 
 
Figure 1.3.3 - The operating principle of AFM and AFM images of amyloid fibrils. a) Schematic representation of 
AFM measurement. AFM image of b) twisted ribbons, c) helical ribbon d) multi-stranded helical fibril. Adapted from 
[149]. 
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1.4. Objectives 
 
Metal ions have prominent as regulators of structure and function of S100 proteins, whose 
functional and amyloid-type oligomerization has been implicated in pathophysiological processes 
related to neurodegeneration. This work aimed at investigating the metal-ion dependent 
oligomerization of the pro-inflammatory S100A9 protein, in an attempt to gain insights into 
understanding how binding of zinc and calcium influence its self-assembly. Specific objectives 
included: 
 
 Obtaining highly pure preparations of human homodimeric S100A9 protein through 
recombinant expression, chromatographic purification, and preparation and 
biochemical characterization of apo-forms; 
 Comprehensive analysis of the S100A9 self-assembly reaction in the presence of Ca2+ 
and Zn2+ using fluorescence based kinetic assays and extrinsic dyes; 
 Conformational characterization of S100A9 oligomers and aggregates combining 
biophysical, biochemical and immunological approaches. 
 
The work reported in this thesis was carried out in the research laboratories of the ‘FCUL 
Protein Folding and misfolding laboratory’ (http://folding.fc.ul.pt/) which is affiliated to BioISI 
– Biosystems & Integrative Sciences Institute and is located at the FCUL Chemistry and 
Biochemistry Department (C8 building FCUL campus). The AFM measurements and analysis 
was performed by collaborators at the BioISI Magnetic Nanosystems Group / Department of 
Physics, also at FCUL (see acknowledgments). 
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2.1. Expression and purification 
 
2.1.1. S100A9 homodimer expression and purification 
The following expression and purification steps were adapted from [114]. The 
recombinant human S100A9 was expressed in E.Coli BL21 (DE3) cells transformed with a 
plasmid containing the S100A9 gene. The first step of the expression was the preparation of a 
pre-inoculum, where a previously prepared glycerol cell culture stock was added to a DYT 
medium, supplemented with 100 mg/mL ampicillin and 20% (m/v) glucose, and incubated 
overnight at 37 °C with 150 rpm agitation. From this pre-inoculum, 10 mL were transferred to a 
0.5 L DYT medium, supplemented with 100 mg/mL ampicillin and 20% glucose and incubated 
at 37 °C with 150 rpm agitation until OD600 = 1 was achieved. At this point expression was 
induced by adding 0.5 mM of IPTG. After 4h of incubation, the cells were harvested by 
centrifugation (JA-14 rotor) with 8000 rpm for 10 min at 4°C and then frozen. 
The purification step begins with the resuspension of the cells in 20 mM Tris-HCl pH 8, 
with DNase (for DNA degradation) and 0.5 mM of PMSF (to inhibit proteases). After 
solubilization, cells were broken by sonication (50% amplitude and 0.5 on/off cycles, during 10 
min) and then centrifuged (JA-25.5 rotor) at 16000 rpm for 20 min. The supernatant was discarded 
and the pellet resuspended in 20 mM Tis-HCl pH 8, 10 mM EDTA, 0.5% (v/v) Triton X-100 
followed by sonication and centrifugation in the same conditions as above, obtaining the inclusion 
bodies. The pellet obtained from this centrifugation was resuspended in 6 M guanidine-HCl, with 
the help of a membrane homogenizer, in order to extract the proteins from the inclusion bodies. 
After 1h, the extract was diluted with 20 mM Tris-HCl pH 8, 1 mM EDTA, 1 mM EGTA and 0.5 
mM DTT in order to decrease guanidine-HCl concentration to 1 M. This extract was then 
centrifuged (16000 rpm, 20 min), the supernatant collected, filtered and loaded into a desalting 
chromatography column (HiTrap desalting) to separate the proteins from guanidine. Afterwards, 
the fractions obtained that corresponded to proteins were loaded into a size-exclusion 
chromatography column (Superdex 75 16/600) against 20 mM Tris-HCl, 1 mM EDTA, 1 mM 
EGTA, 150 mM NaCl pH=8 and 0.5 mM DTT. Using the calibration curve from this column it 
was possible to discriminate which fractions contained S100A9 homodimer. At last, those 
fractions were then passed through an ionic-exchange chromatography column with an ionic 
gradient from 0 to 1 M NaCl. The two elution buffers for this final step were A: 20 mM Tris-HCl 
pH=8, 1 mM EDTA, 1 mM EGTA, 0.5 mM DTT and B: Tris-HCl pH=8, 1 mM EDTA, 1 mM 
EGTA, 0.5 mM DTT, 1 M NaCl. 
Since the beginning of the purification, extracts were always kept on ice and the 
chromatography steps were made in a cold chamber at 4ºC. 
 
 
2.1.2. S100A9 demetalation 
In order to remove possible metal ions bound to the protein, S100A9 was incubated 2 
hours at 37°C, in presence of dithiothreitol (DTT) 300-fold protein concentration (redox reagent) 
to avoid possible disulfide bond formation and 0.5 mM of ethylenediaminetetraacetic acid 
(EDTA) to chelate metal ions. After incubation, protein sample was loaded into a size-exclusion 
chromatography column (Superdex 75 10/300 GL, GE Healthcare, Vcolumn=24 ml) with 50 mM 
Tris-HCl pH 7.4, prepared with metal-free water (chellex water), to separate existing multimers 
formed during incubation, DTT and EDTA, obtaining pure S100A9 demetaled (apo form). 
Protein was then stored at -4ºC in concentrations ranging from 80 to 120 µM. 
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2.1.3. Determination of S100A9’s concentration 
Since S100A9 has aromatic residues it can absorb UV light at 280 nm. So, knowing the 
extinction coefficient (ε) for S100A9 monomer protein (ε280nm= 6,990 M−1.cm−1), we could 
measure the absorbance in a UV/Vis spectrometer and calculate the protein’s concentration 
protein using Beer-Lambert’s law (A = εlc, where l is the path length of the spectrometer). 
Considering that we worked with S100A9 homodimer, it was required to multiply ε by 2 to 
calculate the homodimer concentration. 
Other method used to determine protein’s concentration was the Bradford method, which 
is a colorimetric assay based on the interaction between Coomassie brilliant blue and the arginine 
and aromatic residues in your protein, which leads to shift in its maximum absorption from 470 
nm to 595 nm. By creating a standard curve with the absorbance of a series of known 
concentrations of BSA, we can used it to calculate the concentration of our protein sample based 
on its absorbance. Samples were prepared by mixing 600 µL Bradford reagent (0.1 mM 
Coomassie Blue, 4.75% ethanol, 8.5% (m/v) phosphoric acid) with 20 µL of protein sample. 
 
2.1.4. Electrophoresis 
Since S100A9 has a molecular weight of ~13 kDa it was required to make gels with higher 
resolution/separation for smaller proteins. To do so we prepared a Tris-Tricine SDS-PAGE gel. 
First, the resolving gel was prepared with 8% of acrylamide/bis-acrylamide (29:1 solution), 1M 
Tris 0.1% SDS pH 8.45, 0.05% of amonia persulphate (APS), 8 mM TEMED and finished my 
adding H20. After polymerization of the resolving gel, the stacking gel was added (prepared with 
3.2% acrylamide/bis-acrylamide (29:1), 0.67 M Tris pH 8.45, 0.067% SDS, 0.03% of APS, 13 
mM TEMED and finished by adding H20). 
Samples were prepared by my mixing them with loading buffer (3% SDS, 5% 2-
mercaptoethanol) in 1:1 ratio and incubated ~10min at 100 ºC to denature proteins. For the 
purpose of this method two running buffers were used: cathode buffer (0.1M Tris, 0.1M Tricine, 
0.1% SDS with pH 8.25) and anode buffer (0.2M Tris, pH 8.9). The voltage used was 150V. After 
running the gels, these were stained with BlueSafe solution (Nzytech) for ~2 hours (no distaining 
required). When accurate concentration was necessary, samples were applied with 10µM. 
 
 
2.2. Morphology, structural and kinetic studies 
2.2.1. Aggregation Assays 
Aggregation assays were performed by fluorescence spectroscopy through binding of 
different fluorescent probes: ThT (sigma); ANS; and the LCOs, p-FTAA and h-FTAA. The used 
probes concentration were 40 µM ThT, 100 µM ANS and 0.2 µM LCOs. Samples were prepared 
in 50 mM Tris-HCl pH 7.4 (in chellex water), in the presence of 5 mM TCEP and one of the 
probes. Protein concentration range went from 5 to 40 µM, but 20 µM was the concentration 
mainly used. These assays were also done in presence of metal ions, such as zinc (Zn2+) and 
calcium (Ca2+), whose concentrations ranged from 20 to 200 µM. The 96-well plates (black, clear 
bottom, Corning) were analyzed in the FluoStar Optima (BMG Labtech) and the 
excitation/emission filters used were 440/480 nm for ThT, 370/480 nm for ANS, 440/480 nm for 
p-FTAA. For the h-FTAA, there no filters available, so we used the Gemini EM Microplate 
Reader because it has a monochromator, which was set to 360/408 nm (excitation/emission). The 
kinetics were done with incubation temperature of 37 °C and 86 rpm agitation cycles of 20 
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seconds before each acquisition. In order to optimize each probe’s signal to detect S100A9 
assemblies, this probes were first tested in a fluorimeter and their spectra were acquired. 
 
2.2.2. Turbidimetry 
The aggregation of S100A9 in the presence of different zinc concentrations was 
determined by measuring the apparent absorbance at 360 nm caused by increased turbidity. The 
aggregation was followed in the FluoStar Optima (BMG Labtech), using 96-well transparent 
plates. Samples were prepared in 50 mM Tris-HCl pH 7.4 (in chellex water), in the presence of 5 
mM TCEP. 
In each experiment, the total volume in per well was 200 µL and the aggregation was 
started by the addition of zinc. The apparent absorbance was measured as a function of time. The 
measurements were performed with incubation temperature of 37 °C and 86 rpm agitation cycles 
of 10 seconds every 3 min. The effects of EDTA addition to S100A9 metal-induced aggregates 
were also analyzed in this experiment. 
 
 
2.2.3. Dot-blot Analysis 
S100A9 conformational state was analyzed by its reactivity against conformation 
dependent antibodies was carried out in a dot-blot analysis as described in [148] using the anti-
amyloid fibrils OC antibody (AB2286 Merck Millipore) and the A11 anti pre-fibrillar oligomers 
antibody (AB9234 Merck Millipore). Samples were analyzed after 25 hour incubation with Ca2+ 
and/or Zn2+. 
This experiment begins with the preparation of the PVDF membrane for blotting. Firstly, 
wet the membrane with 100% methanol for a few seconds, then with water and finally with 
transfer buffer (25 mM Tris, 192 mM Glicine, 10% methanol and 0.1% SDS), incubate 2-3 
minutes. Next, samples were applied in each dot (5 or 10 µL) and left overnight. The second part 
begins with washing the blotted PVDF membrane twice with TBS-T buffer (50 mM Tris and 
0.1% NaCl with 0.05% Tween) and then was blocked in TBS containing 5% non-fat dry milk for 
30 min at room temperature with agitation. Afterwards, the blotted membrane was incubated with 
1:1000 dilution of OC (10uL/10mL) antibody and 1:500 dilution of A11 (20uL/10 mL) for 2 h 
with agitation. Later, to remove the unbound antibodies the membrane was washed 4 times with 
TBS-T for 5 minutes each. Next, the membrane was incubate with HRP-coupled secondary anti-
body (5uL/10mL) in TBS-T milk for 1 hour with agitation and then, after this time, washed again 
4 times in TBS-T for 5 minutes each. Finally ECL solution was used according to manufacturer 
(ECL Bio-Rad, mix equal volumes of solution A and solution B) for enhanced 
chemiluminescence and the result was visualized using the Chemidoc visualization system (Bio-
Rad). 
 
 
2.2.4. Atomic force microscopy (AFM) assay 
Aggregated protein samples were deposited on the surface of freshly cleaved mica (Agar 
Scientific) for 10-30 min, washed 3 times with 100 µL of deionized filtered water, to remove 
unwanted contaminants, and dried with a nitrogen source and then subjected to AFM analysis. 
The samples were prepared from different time points of the aggregation kinetic obtained in 
distinct conditions. The volume applied on mica was 20 µL with a final concentration of 1 µM. 
The AFM measurements and analysis was performed by collaborators at the BioISI Magnetic 
Nanosystems Group / Department of Physics, also at FCUL (see acknowledgments). 
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2.2.5. Analytical size exclusion chromatography (SEC) 
Analytical SEC was performed at room temperature on a Superdex 75 Tricorn high 
performance column (GE Healthcare, Vcolumn =24 ml) connected to an AKTA Purifier UPC-10 
system and run at 1 ml/min. The column was calibrated with proteins of known molecular weight:  
ribonuclease A (13.7 kDa), cytochrome c (11.8 kDa), carbonic anhydrase (29 kDa), ovalbumin 
(43 kDa) and albumin (67 kDa). Calibration curve is the appendix section (Figure 2.2.1Erro! A 
origem da referência não foi encontrada.). Samples were incubated 25 h at 37 °C with 250 rpm 
agitation. Before injection (Vinj= 500 µL), samples were centrifuged 5-10min with 14000 rpm.  
The running buffer was 50 mM Tris-HCl pH 7 with 30 mM NaCl. 
 
 
Figure 2.2.1 - Calibration curve used for S100A9 self-assembly analysis by SEC.  
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3.1. Purification of S100A9 homodimer 
Protein purification relies on the knowledge about the protein’s characteristics, such as size, 
isoelectric point (pI) and interactions. The expression and purification of S100A9 homodimer was 
adapted from [114] and optimized in previous work in our laboratory. In order to obtain pure 
S100A9 homodimer a series of processes to isolate the protein have to be done, as depicted in the 
diagram below (Figure 3.1.1). 
 
Figure 3.1.1 – Diagram of purification steps for S100A9 homodimer. 
 
In the first part of the purification 15g of E. coli cells expressing recombinant human 
S100A9 underwent a sequence of steps in order isolate inclusion bodies and then extract the 
proteins within, including S100A9, by adding guanidine. This extract was then submitted to a 
desalting chromatography to separate proteins from the guanidine since the prolonged presence 
of this compound may permanently lead to protein misfolding. The result of this step can be 
observed below (Figure 3.1.2). 
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Figure 3.1.2 – Desalting chromatography purification step. (A) Chromatogram with Abs280nm vs elution volume (Ve). 
(B) SDS-PAGE: 1-standarts; 2-protein extract injected; 3-fractions from 2nd peak; 4-fraction from between peaks; 5-
fraction from 1st peak. 
 
The conductivity of the solution (red curve) increases when guanidine passes through the 
sensor, providing an easy way to discriminate the presence of this compound. As depicted in 
Figure 3.1.2 B lanes 2, 3 and 4 from the SDS-PAGE gel shows that this step was successful and 
now proteins are free from guanidine (black square), although some were retained in the guanidine 
fractions. 
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Afterwards, the protein extract was loaded into a size-exclusion chromatography column. 
Knowing that S100A9 homodimer has a molecular weight of approximately 26 kDa and using 
the calibration curve of the column (Figure 3.1.3 B) it was possible to predict which fractions 
contained S100A9 homodimer (Figure 3.1.3). 
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Figure 3.1.3 - Size-exclusion chromatography purification step. (A) Chromatogram with Abs280nm vs elution volume 
(Ve). (B) Calibration curve for the size-exclusion chromatography column used in purification of S100A9. (C) SDS-
PAGE with different fractions of this step: 1-standarts; 2,3-fractions from 2nd peak (red square); 5,6,7- fractions from 
1st peak (green square). 
 
In the chromatogram depicted above in Figure 3.1.3 are represented the different peaks 
that contain a variety of proteins separated by size. According to the calibration curve the elution 
of S100A9 homodimer occurs at a specific column volume, which strikingly corresponds to the 
highest peak in Figure 3.1.3 A (green square). This assumption was further confirmed by SDS-
PAGE (Figure 3.1.3 B). The presence of S100A9 in the second peak was believed to be an 
S100A9 hexamer (red square), according to the calibration curve, formed during the purification 
initial steps. 
Lastly, the fractions collected were then passed through an ionic-exchange 
chromatography column with an ionic gradient from 0 to 1M NaCl. The results from this step are 
represented below (Figure 3.1.4).    
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Figure 3.1.4 – Ionic-exchange chromatography purification step. (A) Chromatogram with Abs280nm (black line) and 
buffer B % (red line) vs elution volume (Ve). (B) SDS-PAGE showing purified S100A9 homodimer. 
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The S100A9 homodimer was eluted at 28% of buffer B, i.e. 280mM of NaCl, and by 
analyzing the SDS-PAGE gel in Figure 3.1.4 B, it is evident that the eluted protein is highly pure. 
Given that the main aim of this study was to evaluate the effect of metal ions (Ca2+ and 
Zn2+) on S100A9, it was necessary to demetale the protein. Therefore, the sample was incubated 
with DTT and EDTA and then loaded into size-exclusion chromatography column in order to 
obtain purified metal-free S100A9 homodimer (apo form). The amount of protein purified was 
approximately 110 mg, giving a total yield of 7 mg protein/g cells. 
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3.2. Zinc and Calcium binding effects on S100A9 
aggregation 
 
S100A9 is a Ca2+- and Zn2+-binding protein highly abundant in the brain which has been 
reported to be overexpressed in many inflammatory conditions [89]. Moreover, it has been 
proposed that due to its inherent amyloidogenicity, high levels of extracellular S100A9 leads to 
its amyloid aggregation [137-139]. This protein can assume different forms: dimer, tetramer and 
larger oligomers, such as fibrillary structures [91]. The formation the different structures is 
thought to be dependent on metal-binding. For this reason, it is of great importance to study the 
interplay between Ca2+- and Zn2+-binding to S100A9 and how they affect oligomerization. 
 
 
3.2.1. Analysis of the formation of zinc-dependent aggregates 
 
In order to test the self-assembly of the S100A9 homodimer, aggregation assays were 
performed and analyzed kinetically by fluorescence spectroscopy through binding of ThT, a probe 
used specifically for detection of amyloid structures [143].  
Firstly, we wanted to investigate if Zn2+ binding to S100A9 influences its self-assembly 
reaction. Hence, we tested the effect of Zn2+ in excess conditions (4Zn:S100A9), according to 
[108], and different S100A9 concentrations to uncover the critical concentration to aggregate 
(Figure 3.2.1). 
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Figure 3.2.1 – Zn2+ enhances apo-S100A9 aggregation. (A) apo-S100A9 concentration gradient. (B) effect of 4Zn on 
the same S100A9 concentration gradient. (C) Zoom of red section marked in B 
 
Interestingly, when comparing the free-zinc scenario (panel A) with the presence of 4Zn2+ 
(panel B) from Figure 3.2.1 we observed that Zn2+ is capable of inducing S100A9 self-assemble 
and formation of ThT-positive structures. However, this does not confirm that amyloid structures 
are formed. Indeed ThT is known to bind β-sheet-rich and non-β-sheet cavities [144]. In panel B 
can be observed that the classic sigmoidal curve did not occur but instead it seems to be almost 
exponential, with a barely existent lag phase, a characteristic of remarkable fast aggregation. This 
aggregation occurred only for S100A9 in concentrations above 10µM, being the critical 
concentration for S100A9 to aggregate in presence of Zn2+. Furthermore, higher protein 
concentration correlated with a higher fluorescence intensity, higher rate (higher slope) and a 
decrease in the lag phase, from ~2 hours (10µM S100A9) to what seems instantaneous (40µM 
S100A9), suggesting a faster formation of aggregates (Figure 3.2.1 C). In conclusion, the binding 
of Zn2+ leads to the enhanced aggregation of S100A9, in a concentration-dependent manner. 
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We stipulated 20µM of S100A9 as the concentration for the majority of the following 
experiments, since at this concentration the short lag phase (t~30min) and the transition to the 
elongation phase could be observed with detail.  
Afterwards, we assessed the effect of Zn2+’s concentration on S100A9 by making a 
gradient of Zn2+ from 0 to 8-fold relative to the protein concentration (Figure 3.2.2). 
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Figure 3.2.2 – Zn2+ gradient induces further aggregation. (A) S100A9 submitted to a Zn2+ gradient from 0 to 8-fold 
protein’s concentration. (B) ThT fluorescence variation represented for each Zn/S100A9 ratio. 
 
As depicted in Figure 3.2.2, the low ratios of Zn/S100A9, such as 0.5-3Zn/S100A9, were 
incapable of promoting S100A9 self-assembly. In fact, these ratios led to less ThT-binding than 
the apo form. For ratios above 4Zn/S100A9 an enhanced aggregation occurred, where the higher 
Zn content correlates with higher ThT fluorescence. Additionally, there was a simultaneous 
decrease of the lag phase and an increase of the slope, which are traits of a faster aggregation. 
The Zn2+-induced aggregates appeared, macroscopically, as a white precipitate (Figure 
3.2.3 D), conferring a turbid appearance to the solution. As such, the solution’s turbidity was 
measured at 360 nm in order to make correlations with the ThT kinetics. Both S100A9 and zinc’s 
concentration gradients were used to better understand this Zn2+-induced aggregation behavior. 
Zinc-free samples were prepared directly on the plate, and only after 30 minutes of measurements 
the Zn2+ was injected into each well with the desired concentration. Moreover, to see if the already 
formed Zn2+-induced aggregates were reversible, we tested the effect of EDTA, a powerful 
chelating agent that is able to bind Zn2+ (added at t=12h). 
On Figure 3.2.3 A, 20µM of S100A9 was titrated with Zn2+ ranging from 0 to 10-fold of 
S100A9’s concentration. For ratios above 4Zn/S100A9 an instantaneous increase of turbidity was 
observed upon the addition of the metal. However, this phenomenon was only observed for 
concentrations of S100A9 above 10µM (Figure 3.2.3 B). Furthermore, the addition of EDTA at 
12 hours successfully chelated Zn2+ and reverted the solution turbidity to its initial state. Figure 
3.2.3 D shows, in a macroscopic point of view, the effect of EDTA displayed in the turbity 
kinetics, where is visible the regain of solution’s transparency. 
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Figure 3.2.3 – Zn2+-dependent aggregates formation and its reversion by EDTA. (A) Zn2+ gradient over S100A9. (B) 
Effect of 4Zn/S100A9 for different protein concentrations. (C) Native-PAGE of the S100A9 incubated samples with 
different Zn2+ concentrations. Each pair of wells has the samples before (wells 3, 5, 7 and 9) and after (4, 6, 8 and 10) 
addition of EDTA. Black arrows highlights smear. Apo-S100A9 was also loaded without (well 1) and with incubation 
(well 2) conditions. (D) Plate wells display solution’s macroscopic appearance and the effect of EDTA. 
 
Next, the aggregates formed in the experiment depicted in Figure 3.2.3 A were loaded 
into a Native-PAGE (Figure 3.2.3 C), before (black arrow) and after addition of EDTA to 
investigate the possibility that EDTA not only recovers solution transparency but also induces 
disruption of Zn2+-induced aggregates. When comparing the well pairs, it’s possible to observe 
that Zn2+ led to formation of a smear effect on the gel and that no other bands are visible. One 
could speculate that this smear results from S100A9 conformers induced by Zn2+ binding. In 
conclusion, adding to the previous results from ThT aggregation assays, zinc is capable of 
inducing S100A9 homodimer aggregation in a way that leads to the formation of insoluble ThT-
reactive aggregates visible to a point where turbidity monitoring is possible. Formation of these 
aggregates is dependent on the 4Zn:S100A9 ratio and occurs strikingly fast. Furthermore, EDTA 
was capable of reversing the effect of Zn2+ in S100A9 aggregation. Additionally, ThT-binding 
displayed same EDTA behavior (Figure 3.2.4). 
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Figure 3.2.4 – ThT-kinetics show EDTA effect (added at 5 hours of incubation). 
 
This type of aggregation could be driven by an electrostatic effect that alters protein 
solubility (salting out effect), however ThT-kinetics of S100A9 homodimer with excess of NaCl 
did not reproduce this aggregation (data not shown).  
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Afterwards, knowing that Zn2+ was able to induce S100A9 self-assembly, we wanted to 
investigate the morphology of the formed structures. For this purpose the S100A9 samples from 
the aggregation assays end points were analyzed by atomic force microscopy (AFM). 
 
Figure 3.2.5 - Correlation between ThT kinetics and AFM imaging of apo S100A9 and 4Zn/S100A9 incubated 25h at 
37ºC with 250rpm agitation. Panel (A) and (B) display the effect of Zn2+ on S100A9. Scan size of 2 and 1 µm, 
respectively. Panel (C) and (D) display apo S100A9 self-assembly. Scan size of 1 µm. 
 
As depicted in Figure 3.2.5 A and B, imaging of incubated S100A9 in the presence of 
Zn2+ at a ratio of 4:1 showed that this condition induced the formation of amorphous aggregates 
with a flat sphere shape. Interestingly, statistics showed that this aggregates have a height of ~8 
nm and a diameter of ~33.5 nm (data not shown), suggesting formation of structures with a size 
close to the tetramer [108]. The need of excess of Zn2+ to develop this structures might be 
explained by a study focused on S100A8/A9 where was reported that Zn2+ could bind not only to 
Zn2+-specific sites but also to the Ca2+-binding sites, inducing tetramerization [113, 114]. 
Regarding the metal-free S100A9, the images above (C and D) evidence the formation of 
different string-like structures with variable length. 
 
Figure 3.2.6 - AFM imaging of EDTA effect on Zn2+-induced aggregates. Scan size of 5 µm. 
 
We took advantage of AFM imaging to visualize EDTA effect on the Zn2+-induced 
aggregates. In Figure 3.2.6 can be observed that EDTA led to the disruption of the Zn2+-dependent 
aggregates, by chelating the Zn2+ bound to S100A9, in agreement with the observed loss of turbity 
and ThT emission decay. 
As described earlier, a characteristic of amyloid formation is that this phenomenon can 
be triggered by seeding [47, 48] from existing aggregates. The kinetic changes induced by a 
seeding event include formation of larger aggregates and elimination of the lag phase. To test the 
effect of seeding, 25 hour incubation Zn2+-induced aggregates were used to seed aggregation of 
S100A9 alone and in presence of Zn2+ at a ratio of 4:1. 
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Figure 3.2.7 – Zn2+-induced aggregates seed aggregation of 4Zn:S100A9. (A) 50 hour monitoring of seeding effect by 
adding 20%, 10% and 5% of aggregates. (B) Zoom of the first 3 hours (red section in A). 
 
 As it is depicted in Figure 3.2.7 A, seeding of 4Zn:S100A9 resulted in higher ThT 
fluorescence, as increasing amounts of aggregates were added. However, the lag phase seems 
unchanged (panel B). Moreover, in Figure 3.2.8 B, can be observed that the aggregates alone did 
not account for the gained ThT fluorescence observed, meaning that is not just adding 
fluorescence from individual events. On the other hand, seeding of apo S100A9 led to lower ThT 
reactivity (Figure 3.2.8 B), suggesting an interaction between the apo S100A9 and the Zn2+-
induced aggregates that resulted in a formation of ThT non-reactive species, possibly due to a 
stabilizing effect of the protein structure. Overall, the occurrence of seeding was not obvious and 
therefore we cannot conclude what happened to the aggregates, as they were not analyzed by 
AFM. 
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Figure 3.2.8 – No seeding effect on apo-S100A9. (A) Different amounts of Zn2+-induced aggregates added to 
S100A9 homodimer. (B) Control - aggregates alone. 
 
Aiming to shed light on the conformational changes induced by Zn2+ and to identify 
possible intermediate structures, different probes, such as ANS, p-FTAA and h-FTAA, were used 
to analyze S100A9 alone, in presence of 4:1 and 6:1 Zn/S100A9 ratio. 
ThT is the probe mostly used to detect amyloid fibrils [143] but is has been shown to bind 
also to non-β-sheet cavities [144]. On the other hand, ANS is known to interact with hydrophobic 
sites, such as the ones exposed when protein starts to aggregate [142]. Lastly, p-FTAA and h-
FTAA (LCOs), each with a distinct optical signatures, are capable of detecting non-
thioflavinophilic aggregated species such as the ones preceding amyloid fibril formation, but how 
these probes interact is still to be explained [146]. 
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Figure 3.2.9 – Comparison of kinetic profiles obtained for S100A9 alone, 4:1 and 6:1 ratio of Zn/S100A9, with 
different probes. 
 
Comparing the kinetic profile obtained with each probe for the apo S100A9, it is possible 
to observe that, in absence of divalent metal ions, the conformational changes that occurred did 
not result in the formation of amyloid structures, since no significant fluorescence was observed 
(for ThT, ANS and p-FTAA). ThT reactivity suggests a slow increasing of ThT-reactive species 
and in small quantities. On the other hand, ANS binding did not occur, meaning that there was no 
hydrophobic regions exposed, during the incubation period. Regarding p-FTAA and h-FTAA, 
they showed contradictory effects, which was rather surprising given that both are expected to 
interact with same type of species, however this interaction is known to occur differently. For this 
reason, it is possible that h-FTAA is able to detect species that p-FTAA cannot. Overall, none of 
this probes seemed to be the best fit to report what is happening to apo S100A9, however we 
could exclude the possibility of amyloids formation. 
Regarding the effect of Zn2+ on S100A9 aggregation, all probes exhibited reactivity, 
indicating occurrence of a complex self-assembly reaction. For the 4Zn/S100A9 ratio, some 
differences are visible from each probe. It seems that ThT-positive species are being formed faster 
than the supposed intermediates detected by LCOs. Moreover, the formation of ThT- and non-
ThT reactive species appears to be associated with the exposition of hydrophobic regions 
(reported by ANS), due to major conformational adjustments. However, the h-FTAA profile 
indicates what it seems to be the occurrence of a second event, starting at ~12h. In situations with 
higher amounts of zinc, in this case 6Zn/S100A9, reactivity for all probes continues to occur, but 
with a higher rate (higher slope), fluorescence intensity and shorter lag phase, meaning that this 
event is, as expect from earlier results, enhanced with increasing amounts of zinc. However, the 
minor details in the kinetic profiles, reported for the 4:1 ratio, are no longer observable. Overall, 
the Zn2+-induced S100A9 aggregation reported by ThT was also described by the LCOs and ANS, 
demonstrating this phenomenon complexity. 
38 
 
3.2.2. Analysis of the formation of Ca-dependent aggregates and the 
effect combined of Zn and Ca 
 
The abovementioned findings about zinc’s ability to induce S100A9 aggregation led us 
to investigate the possibility of calcium alone or with zinc being also capable of similar effects. 
As it has been previously described for other S100 proteins, the S100A9 homodimer has four 
Ca2+-binding sites [108]. Hence, in the following assays we incubated the S100A9 homodimer 
with Ca2+ alone, ranging from 0 to 4-fold protein’s concentration, and in combination with Zn2+. 
We did a Ca2+ gradient over a non-aggregating Zn/S100A9 ratio and a Zn2+ gradient (0 to 3-fold 
protein’s concentration) over a full Ca2+-loaded S100A9 homodimer to see how these two metals 
together influence S100A9 self-assembly. 
 
 
Figure 3.2.10 – Binding of both Ca2+ and a transition metal (in our case, Zn2+) to S100 protein. 
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Figure 3.2.11 – Zn2+ and Ca2+ together induced S100A9 aggregation. (A) Ca2+ gradient over a non-aggregator Zn2+ 
concentration. (B) Zn2+ gradient over a full Ca2+-loaded S100A9 homodimer. 
 
Since calcium is a natural ligand of S100A9 one should expect that Ca2+-binding would 
not induce amyloid aggregation of S100A9, which was indeed confirmed by the kinetic data 
above represented (Figure 3.2.11), where low ThT reactivity was observed when Ca2+ was present 
at 4:1 ratio of Ca/S100A9 (pink curve in panel A). Surprisingly, increasing concentrations of Ca2+ 
induced S100A9 aggregation when loaded with non-aggregating Zn concentration (panel B) and 
vice versa (panel A). Furthermore, the sample, similarly to 4Zn/S100A9 condition, became turbid 
and formed a precipitate. 
Overall, the data above demonstrated an additive effect, where the formation of ThT-
reactive species was induced by concomitant addition of Ca2+ and Zn2+ to S100A9 at specific 
concentrations. 
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Figure 3.2.12 – Correlation between ThT kinetics and AFM imaging of S100A9 4Ca samples incubated 25h at 37ºC 
with 250rpm agitation. Images with different scan sizes: (A) 2 µm, (B) and (C) 1 µm 
  
 As it is depicted in Figure 3.2.12, the presence of 4Ca induced the formation of string-
like structures similar to the ones obtained for S100A9 alone, however these ones were bigger 
with a length of 439 ± 32 nm. Since Ca2+ is considered to be a natural ligand of S100A9 and the 
aggregation assays did not show amyloid-like behaviour, therefore we put forward the possibility 
that these structures can be some kind of functional aggregates. Considering the results for the 
apo S100A9, it is possible to hypothesize that this features can be formed by S100A9 alone and 
that Ca2+ may have a role in accelerating this process. Additionally, images from 5, 15, 25 hours 
showed a polymerization reaction (Figure 3.2.13). 
The concomitant addition of 4Ca2+ and 4Zn2+ to S100A9 lead to formation of a wide range 
of fibril-like structures and also some amorphous aggregates. The presence of the two metals 
could be the key to produce amyloid fibrils. This hypothesis has already been proposed for 
S100A8/A9 [115]. 
 
 
Figure 3.2.13 – AFM imaging shows polymerization reaction induced by Ca2+. Images taken at 5, 15 and 25 hours of 
incubation. 
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We then tested the effect of EDTA on these metal-induced structures to see if it could 
revert to its initial state. 
 
 
Figure 3.2.14 – AFM imaging of EDTA effect on metal-dependent S100A9 structures. 
 
Interestingly, the amount of Ca2+-induced strings was lower after addition of EDTA, as 
well as their length, becoming more similar to the ones formed by the apo S100A9. Statistics 
showed that their length went decreased from 439 ± 32 nm to 268 ± 18 nm. Lastly, the fibrils 
observed in S100A9 4Zn 4Ca condition disappeared or became smaller. Overall, the EDTA effect 
showed that without metals these assemblies become less stable, therefore leading to some degree 
of dissociation. 
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Afterwards, similarly to what was performed for Zn2+ effect on S100A9, the same probes 
were used to further analyze the conformational changes induced by Ca2+ alone and with Zn2+. 
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Figure 3.2.15 - Comparison of kinetic profiles obtained for S100A9 alone, 4:1 Ca/S100A9 ratio and 4:4:1 
Ca/Zn/S100A9 ratio, with different probes. 
 
The interaction between S100A9 and 4Ca2+, revealed similar kinetic profiles, for each 
probe, to the ones of apo S100A9, suggesting that the similar conformational changes are 
happening. Interestingly, the combined effect of 4Zn2+ and 4Ca2+ on S100A9 was reported by all 
probes. However the results suggest a distinct aggregation pathway from the other conditions. In 
this case, ANS and p-FTAA reactivity appeared to be superimposable, suggesting formation of 
intermediate species with exposure of the protein’s hydrophobic patches, and later ThT reactivity 
suggests formation of amyloid structures, possibly fibrils (seen in Figure 3.2.12 A). On the other 
hand, h-FTAA showed that non-ThT reactive species were formed in a mid-stage of the recorded 
process, contributing to complexity of this self-assembly.  
Overall, the 25 hour incubation of S100A9 with Ca2+ occurred in a very similar way than 
the apo S100A9. Although these probes were incapable of describing the conformational changes 
induced by Ca2+, it is possible to assume that this phenomenon is greatly distinct from the other 
conditions. Regarding S100A9 binding to both Zn2+ and Ca2+, a complex aggregation occurred 
with formation of amyloid-like structures. 
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3.2.3. Imunodetection and SEC analysis discriminate metal-induced 
structures 
 
To further characterize the S100A9 aggregates in the presence of the studied metal ions, 
conformation-dependent antibodies that specifically recognize polypeptide chains with a given 
conformation, were used. The antibodies used were the OC and A11. The OC antibody is capable 
of recognizing amyloid fibrils, while the A11 specifically recognizes to prefibrillar oligomers 
[147, 148].  Different dilutions of the S100A9 samples were tested to assess which condition 
retrieved a stronger reaction with the antibody. 
 
  
Figure 3.2.16 – Dotblot of the 25h end-points of metal-induced aggregates. (A) OC reactivity to amyloid fibrils (B) 
A11 reactivity to prefibrillar oligomers. 
 
This experiment (Figure 3.2.16) revealed that the incubation of S100A9 with 4Zn2+ and 
4Ca2+ resulted in formation of species reactive to both antibodies, suggesting therefore the 
presence of amyloid fibrils and also prefibrillar oligomers. On the other hand, for the other 
conditions reaction to A11 was not observed, thus excluding the possibility of existence of 
prefibrillar oligomers. However, low reactivity to OC antibody was observed, which should mean 
presence of amyloid fibrils, but when compared to non-incubated S100A9 for all conditions, it is 
not possible be sure that amyloid fibrils cause this immunoreactivity. 
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Next, we used another approach to assess protein conformational changes by passing proteins 
through a size exclusion chromatography (SEC). This method allows monitoring of protein size 
changes using the column’s calibration curve (Figure 2.2.1), however assuming its globular state. 
The samples were injected in the column after 25 hour incubation at 37 ºC and agitation. Moreover 
the effect of EDTA was also analyzed. The results obtained showed present of only one peak for 
each samples with molecular masses ranging 31-49 kDa (Figure 3.2.17). 
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Figure 3.2.17 – Aggregation analysis by SEC reveals S100A9 species with different sizes. 
 
As it can be observed above, the chromatograms that represent the apo S100A9 and 
4Ca/S100A9 conditions are very similar, with an insignificant difference of ~2 kDa, which is in 
accordance with the similarity described in the experiments discussed earlier. In this conditions, 
the peak displayed a molecular mass of ~37 and ~39 kDa which is larger than the S100A9 
homodimer but smaller then tetramer, meaning that the homodimer could be in a more relaxed 
conformation rather than the classic globular shape, thus appearing larger. 
On the other hand, the chromatogram of 4Zn/S100A9 showed a peak with maximum size 
of ~49 kDa, suggesting formation of S100A9 tetramer, which could be possible considering the 
findings reported in the literature [109] and also the AFM data. 
The analysis of S100A9 in presence of Zn2+ at a 6:1 ratio and in presence of both Zn2+ 
and Ca2+ was impossible to performed, because of the large amount of precipitate that could not 
be loaded into the column. 
 Here, the EDTA did not produce any significant change on apo S100A9 and 
4Ca/S100A9’s chromatogram, however for the other conditions the effect was very interesting. 
After EDTA addition, 4Zn/S100A9 presented a shift of peak to a lower molecular mass, 
suggesting dissociation of tetramer into dimer. Lastly, the recovery of the insoluble protein 
correlated with the arising of a peak, demonstrating once more, the metal dependence of this 
assemblies. Figure 3.2.18 represents how the quantity of soluble protein is altered by metal 
binding and addition of EDTA.  
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Figure 3.2.18 – Changes in quantities of soluble protein induced by metal binding and EDTA. (A) Bar chart 
representing bradford quantification. (B) SDS-PAGE of the respective conditions in chart above. 
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IV. Conclusions 
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Protein misfolding and aggregation events are known to be associated with a variety of 
human disorders, such as Alzheimer’s disease (AD) [140]. In the context of AD, the S100A9 
protein has been proposed to participate as potent pro-inflammatory protein and by forming 
amyloid aggregates, which co-aggregate with Aβ peptide, thus increasing the pathologic state of 
the disease [150]. Considering that S100A9 is a Ca2+ and Zn2+-binding protein and that metals are 
capable of inducing conformational changes [82], one would expect that the interaction of 
S100A9 with these metals could be the source of amyloid aggregation and the cytotoxicity that 
arises with it. 
In this study we have demonstrated an effect of Zn2+ over S100A9 aggregation when 
present in concentrations above its binding capacity [108]. This interaction led to the formation 
of ThT-reactive species but only when S100A9 concentration was above 10µM (critical 
concentration to aggregate). Moreover, increasing concentrations of S100A9 or Zn2+ lead to faster 
aggregation, which presented visually as a white turbid precipitate. The possibility of this 
aggregation could be driven by an electrostatic effect was ruled out by ThT kinetics of S100A9 
with excess of NaCl, since it did not reproduce same effect as Zn2+. The results for other 
aggregation probes are in agreement with the existence of this aggregation phenomenon. 
Furthermore, seeding experiments did not show amyloid-like behaviour, as well AFM imaging 
and imunodetection with OC and A11 antibodies did not display presence of amyloid fibrils, but 
instead this aggregates appeared as individual globular features. Overall, this findings suggest that 
S100A9 forms non-amyloid aggregates which precipitate with a possible role in Zn2+ chelation. 
Regarding the role of Ca2+, its effect was hardly reported by the probes used, excluding 
the formation of amyloid-like structures. Indeed this hypothesis was confirmed by the results from 
immunoreactivity of OC and A11 antibodies who showed no detection. Interestingly, AFM 
imaging assays showed the formation of string-like structures, carried out through a 
polymerization reaction. Hence, we demonstrated that Ca2+ is capable of inducing the formation 
of “aggregates”, however these may have a biological function, rather than a toxic effect.  
When combined together Zn2+ and Ca2+ produced an additive effect that was displayed 
by the binding of the different aggregation reporters, probes and antibodies. Also, the AFM 
imaging showed presence of fibrils in these samples, confirming that the interaction of S100A9 
with these metals leads to formation of amyloidogenic structures.  
Furthermore, we have demonstrated that the assemblies formed are highly dependent on 
metals, as EDTA was capable of disrupting them, differently. Amazingly, EDTA was able to 
recover almost all insoluble protein to a soluble state. 
Altogether, the results from this work contribute to unveil possible mechanisms through 
which Zn2+ and Ca2+ binding influences S100A9 self-assembly reaction and will open new 
avenues for investigations on the roles of such assemblies in pathophysiological conditions. 
In a near future it would be interesting to further characterize the formed species using 
circular dichroism, a technique which would allow us to unveil the alterations in the protein’s 
secondary structure upon metal binding. Furthermore, it would be of great importance to study 
the possible toxicity of each of the species formed in each condition, as to shed light in the 
relevance of S100A9’s interaction with Zn2+ and Ca2+ to the onset of the disease. Finally, we are 
currently using a promising approach which is AFM imaging in solution in order to record the 
whole conformational process induced by Ca2+ and Zn2+ on S100A9.  
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